has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 28.0337 crores during the period ended March 31, 2023 as compared to Rs. 39.7097 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 1.7657 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 2.2495 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 0.21 for the period ended March 31, 2023 as compared to Rs. 0.27 for the period ended December 31, 2022.
Total Income | ₹28.0337 crs | ₹39.7097 crs | -29.40% |
Net Profit | ₹1.7657 crs | ₹2.2495 crs | -21.51% |
EPS | ₹0.21 | ₹0.27 | -22.22% |
Financial Results (Q4 FY2023) - YoY Comparison The company has reported total income of Rs.28.0337 crores during the period ended March 31, 2023 as compared to Rs.33.0139 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.1.7657 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.1.8832 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.0.21 for the period ended March 31, 2023 as compared to Rs.0.23 for the period ended March 31, 2022.
Total Income | ₹28.0337 crs | ₹33.0139 crs | -15.09% |
Net Profit | ₹1.7657 crs | ₹1.8832 crs | -6.24% |
EPS | ₹0.21 | ₹0.23 | -8.70% |
Financial Results (Year Ended FY2023) - YoY Comparison The company has reported total income of Rs.144.3841 crores during the Financial Year ended March 31, 2023 as compared to Rs.123.05 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.7.2415 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.4.8120 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.0.87 for the Financial Year ended March 31, 2023 as compared to Rs.0.58 for the Financial Year ended March 31, 2022.
Total Income | ₹144.3841 crs | ₹123.05 crs | 17.34% |
Net Profit | ₹7.2415 crs | ₹4.8120 crs | 50.49% |
EPS | ₹0.87 | ₹0.58 | 50.00% |
Source : Equity Bulls
Keywords
MedicoRemedies
Q4FY23
FY2023
ResultUpdate